Titre : Sphingolipides

Sphingolipides : Questions médicales fréquentes

Termes MeSH sélectionnés :

Protein Transport

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une maladie liée aux sphingolipides ?

Le diagnostic repose sur des tests génétiques, des analyses biochimiques et des biopsies.
Maladies métaboliques Sphingolipides
#2

Quels tests sont utilisés pour évaluer les sphingolipides ?

Des tests sanguins et des analyses d'urine mesurent les niveaux de sphingolipides.
Analyse sanguine Sphingolipides
#3

Les symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?

Oui, des symptômes neurologiques ou cutanés peuvent signaler un déséquilibre.
Symptômes neurologiques Sphingolipides
#4

Quelle imagerie est utile pour les maladies des sphingolipides ?

L'IRM et la TDM peuvent aider à visualiser les effets des maladies sur les organes.
Imagerie par résonance magnétique Sphingolipides
#5

Les antécédents familiaux sont-ils importants pour le diagnostic ?

Oui, les antécédents familiaux peuvent indiquer une prédisposition génétique aux maladies.
Antécédents familiaux Sphingolipides

Symptômes 5

#1

Quels sont les symptômes des troubles liés aux sphingolipides ?

Les symptômes incluent des troubles neurologiques, des problèmes cutanés et des douleurs.
Symptômes neurologiques Sphingolipides
#2

Les troubles digestifs sont-ils associés aux sphingolipides ?

Oui, certains troubles digestifs peuvent être liés à des anomalies des sphingolipides.
Troubles digestifs Sphingolipides
#3

Comment les sphingolipides affectent-ils le système nerveux ?

Ils jouent un rôle dans la myélinisation et la signalisation neuronale, affectant la fonction nerveuse.
Système nerveux Sphingolipides
#4

Les troubles de la peau sont-ils fréquents avec les sphingolipides ?

Oui, des affections cutanées comme l'eczéma peuvent être liées à des déséquilibres.
Affections cutanées Sphingolipides
#5

Les symptômes varient-ils selon le type de sphingolipide ?

Oui, les symptômes dépendent du type de sphingolipide impliqué et de l'organe affecté.
Types de sphingolipides Sphingolipides

Prévention 5

#1

Peut-on prévenir les maladies liées aux sphingolipides ?

La prévention est difficile, mais un mode de vie sain peut réduire les risques.
Prévention des maladies Sphingolipides
#2

Les tests génétiques aident-ils à la prévention ?

Oui, les tests génétiques peuvent identifier les personnes à risque et guider la prévention.
Tests génétiques Sphingolipides
#3

L'éducation sur les sphingolipides est-elle importante ?

Oui, comprendre les sphingolipides aide à reconnaître les symptômes et à agir rapidement.
Éducation à la santé Sphingolipides
#4

Les habitudes alimentaires influencent-elles la santé des sphingolipides ?

Oui, une alimentation équilibrée peut soutenir la santé des sphingolipides et prévenir des troubles.
Habitudes alimentaires Sphingolipides
#5

Les vaccinations peuvent-elles aider à prévenir des complications ?

Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles liés aux sphingolipides.
Vaccination Sphingolipides

Traitements 5

#1

Quels traitements existent pour les maladies des sphingolipides ?

Les traitements incluent des thérapies enzymatiques, des médicaments et des soins symptomatiques.
Thérapie enzymatique Sphingolipides
#2

La diète peut-elle influencer les niveaux de sphingolipides ?

Oui, une alimentation riche en acides gras essentiels peut aider à réguler les sphingolipides.
Régime alimentaire Sphingolipides
#3

Les médicaments peuvent-ils réduire les symptômes ?

Oui, certains médicaments peuvent atténuer les symptômes et améliorer la qualité de vie.
Médicaments Sphingolipides
#4

Y a-t-il des traitements expérimentaux pour ces maladies ?

Oui, des essais cliniques explorent de nouvelles thérapies pour les troubles des sphingolipides.
Essais cliniques Sphingolipides
#5

La thérapie génique est-elle une option pour ces maladies ?

La thérapie génique est en recherche pour traiter certaines maladies liées aux sphingolipides.
Thérapie génique Sphingolipides

Complications 5

#1

Quelles complications peuvent survenir avec les troubles des sphingolipides ?

Les complications incluent des troubles neurologiques graves, des infections et des défaillances organiques.
Complications Sphingolipides
#2

Les troubles respiratoires sont-ils une complication possible ?

Oui, certains troubles des sphingolipides peuvent entraîner des complications respiratoires.
Troubles respiratoires Sphingolipides
#3

Comment les sphingolipides affectent-ils le cœur ?

Des déséquilibres peuvent contribuer à des maladies cardiovasculaires et à des arythmies.
Maladies cardiovasculaires Sphingolipides
#4

Les complications neurologiques sont-elles fréquentes ?

Oui, des complications comme la démence ou des troubles moteurs peuvent survenir.
Complications neurologiques Sphingolipides
#5

Les complications peuvent-elles être réversibles ?

Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles.
Réversibilité Sphingolipides

Facteurs de risque 5

#1

Quels sont les facteurs de risque pour les maladies des sphingolipides ?

Les facteurs incluent des antécédents familiaux, des mutations génétiques et des déséquilibres nutritionnels.
Facteurs de risque Sphingolipides
#2

L'âge influence-t-il le risque de troubles des sphingolipides ?

Oui, certains troubles apparaissent plus fréquemment chez les enfants ou les personnes âgées.
Âge Sphingolipides
#3

Les maladies auto-immunes sont-elles un facteur de risque ?

Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles liés aux sphingolipides.
Maladies auto-immunes Sphingolipides
#4

Le mode de vie influence-t-il le risque ?

Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque.
Mode de vie Sphingolipides
#5

Les infections peuvent-elles aggraver les troubles des sphingolipides ?

Oui, certaines infections peuvent exacerber les symptômes et les complications.
Infections Sphingolipides
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Sphingolipides : Questions médicales les plus fréquentes", "headline": "Sphingolipides : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Sphingolipides : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-13", "dateModified": "2025-03-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Sphingolipides" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Lipides membranaires", "url": "https://questionsmedicales.fr/mesh/D008563", "about": { "@type": "MedicalCondition", "name": "Lipides membranaires", "code": { "@type": "MedicalCode", "code": "D008563", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycosphingolipides", "alternateName": "Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D006028", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides", "code": { "@type": "MedicalCode", "code": "D006028", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Glycosphingolipides acides", "alternateName": "Acidic Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D020384", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides acides", "code": { "@type": "MedicalCode", "code": "D020384", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Gangliosides", "alternateName": "Gangliosides", "url": "https://questionsmedicales.fr/mesh/D005732", "about": { "@type": "MedicalCondition", "name": "Gangliosides", "code": { "@type": "MedicalCode", "code": "D005732", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } }, { "@type": "MedicalWebPage", "name": "Sulfoglycosphingolipides", "alternateName": "Sulfoglycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D013433", "about": { "@type": "MedicalCondition", "name": "Sulfoglycosphingolipides", "code": { "@type": "MedicalCode", "code": "D013433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.837" } } } ] }, { "@type": "MedicalWebPage", "name": "Gangliosides", "alternateName": "Gangliosides", "url": "https://questionsmedicales.fr/mesh/D005732", "about": { "@type": "MedicalCondition", "name": "Gangliosides", "code": { "@type": "MedicalCode", "code": "D005732", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } } ] }, { "@type": "MedicalWebPage", "name": "Ganglioside GM1", "alternateName": "G(M1) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005677", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM1", "code": { "@type": "MedicalCode", "code": "D005677", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.390" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM2", "alternateName": "G(M2) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005678", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM2", "code": { "@type": "MedicalCode", "code": "D005678", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.400" } } }, { "@type": "MedicalWebPage", "name": "Ganglioside GM3", "alternateName": "G(M3) Ganglioside", "url": "https://questionsmedicales.fr/mesh/D005679", "about": { "@type": "MedicalCondition", "name": "Ganglioside GM3", "code": { "@type": "MedicalCode", "code": "D005679", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.475.510" } } }, { "@type": "MedicalWebPage", "name": "Sulfoglycosphingolipides", "alternateName": "Sulfoglycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D013433", "about": { "@type": "MedicalCondition", "name": "Sulfoglycosphingolipides", "code": { "@type": "MedicalCode", "code": "D013433", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.025.837" } } }, { "@type": "MedicalWebPage", "name": "Glycosphingolipides neutres", "alternateName": "Neutral Glycosphingolipids", "url": "https://questionsmedicales.fr/mesh/D020383", "about": { "@type": "MedicalCondition", "name": "Glycosphingolipides neutres", "code": { "@type": "MedicalCode", "code": "D020383", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Céramides", "alternateName": "Ceramides", "url": "https://questionsmedicales.fr/mesh/D002518", "about": { "@type": "MedicalCondition", "name": "Céramides", "code": { "@type": "MedicalCode", "code": "D002518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } } ] }, { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } }, { "@type": "MedicalWebPage", "name": "Sphingomyéline", "alternateName": "Sphingomyelins", "url": "https://questionsmedicales.fr/mesh/D013109", "about": { "@type": "MedicalCondition", "name": "Sphingomyéline", "code": { "@type": "MedicalCode", "code": "D013109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.870" } } } ] }, { "@type": "MedicalWebPage", "name": "Céramides", "alternateName": "Ceramides", "url": "https://questionsmedicales.fr/mesh/D002518", "about": { "@type": "MedicalCondition", "name": "Céramides", "code": { "@type": "MedicalCode", "code": "D002518", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } } ] }, { "@type": "MedicalWebPage", "name": "Cérébrosides", "alternateName": "Cerebrosides", "url": "https://questionsmedicales.fr/mesh/D002554", "about": { "@type": "MedicalCondition", "name": "Cérébrosides", "code": { "@type": "MedicalCode", "code": "D002554", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } } ] }, { "@type": "MedicalWebPage", "name": "Galactosylcéramides", "alternateName": "Galactosylceramides", "url": "https://questionsmedicales.fr/mesh/D005699", "about": { "@type": "MedicalCondition", "name": "Galactosylcéramides", "code": { "@type": "MedicalCode", "code": "D005699", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.450" } } }, { "@type": "MedicalWebPage", "name": "Glucosylcéramides", "alternateName": "Glucosylceramides", "url": "https://questionsmedicales.fr/mesh/D005963", "about": { "@type": "MedicalCondition", "name": "Glucosylcéramides", "code": { "@type": "MedicalCode", "code": "D005963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.250.490" } } }, { "@type": "MedicalWebPage", "name": "Globosides", "alternateName": "Globosides", "url": "https://questionsmedicales.fr/mesh/D005915", "about": { "@type": "MedicalCondition", "name": "Globosides", "code": { "@type": "MedicalCode", "code": "D005915", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.425" } } }, { "@type": "MedicalWebPage", "name": "Lactosylcéramides", "alternateName": "Lactosylceramides", "url": "https://questionsmedicales.fr/mesh/D007790", "about": { "@type": "MedicalCondition", "name": "Lactosylcéramides", "code": { "@type": "MedicalCode", "code": "D007790", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.612" } } }, { "@type": "MedicalWebPage", "name": "Trihexosylcéramide", "alternateName": "Trihexosylceramides", "url": "https://questionsmedicales.fr/mesh/D014281", "about": { "@type": "MedicalCondition", "name": "Trihexosylcéramide", "code": { "@type": "MedicalCode", "code": "D014281", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.200.906" } } }, { "@type": "MedicalWebPage", "name": "Sphingomyéline", "alternateName": "Sphingomyelins", "url": "https://questionsmedicales.fr/mesh/D013109", "about": { "@type": "MedicalCondition", "name": "Sphingomyéline", "code": { "@type": "MedicalCode", "code": "D013109", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.612.870" } } }, { "@type": "MedicalWebPage", "name": "Psychosine", "alternateName": "Psychosine", "url": "https://questionsmedicales.fr/mesh/D011609", "about": { "@type": "MedicalCondition", "name": "Psychosine", "code": { "@type": "MedicalCode", "code": "D011609", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D10.570.877.360.806" } } } ] } ], "about": { "@type": "MedicalCondition", "name": "Sphingolipides", "alternateName": "Sphingolipids", "code": { "@type": "MedicalCode", "code": "D013107", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Erich Gulbins", "url": "https://questionsmedicales.fr/author/Erich%20Gulbins", "affiliation": { "@type": "Organization", "name": "Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany." } }, { "@type": "Person", "name": "Giovanni D'Angelo", "url": "https://questionsmedicales.fr/author/Giovanni%20D%27Angelo", "affiliation": { "@type": "Organization", "name": "Interfaculty Institute of Bioengineering, Ecole polytechnique fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland giovanni.dangelo@epfl.ch Christopher.Clarke@stonybrookmedicine.edu lianacsilva@ff.ulisboa.pt." } }, { "@type": "Person", "name": "Anna Kovilakath", "url": "https://questionsmedicales.fr/author/Anna%20Kovilakath", "affiliation": { "@type": "Organization", "name": "Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States." } }, { "@type": "Person", "name": "L Ashley Cowart", "url": "https://questionsmedicales.fr/author/L%20Ashley%20Cowart", "affiliation": { "@type": "Organization", "name": "Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States." } }, { "@type": "Person", "name": "Tyrone Dowdy", "url": "https://questionsmedicales.fr/author/Tyrone%20Dowdy", "affiliation": { "@type": "Organization", "name": "Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Protein transport along the presequence pathway.", "datePublished": "2023-05-09", "url": "https://questionsmedicales.fr/article/37155927", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1515/hsz-2023-0133" } }, { "@type": "ScholarlyArticle", "name": "Regulation of Protein Transport Pathways by the Cytosolic Hsp90s.", "datePublished": "2022-08-05", "url": "https://questionsmedicales.fr/article/36008972", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/biom12081077" } }, { "@type": "ScholarlyArticle", "name": "Coping with stress: How bacteria fine-tune protein synthesis and protein transport.", "datePublished": "2023-08-14", "url": "https://questionsmedicales.fr/article/37586589", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jbc.2023.105163" } }, { "@type": "ScholarlyArticle", "name": "IFT-A structure reveals carriages for membrane protein transport into cilia.", "datePublished": "2022-12-02", "url": "https://questionsmedicales.fr/article/36462505", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.cell.2022.11.010" } }, { "@type": "ScholarlyArticle", "name": "The cholesterol transport protein GRAMD1C regulates autophagy initiation and mitochondrial bioenergetics.", "datePublished": "2022-10-21", "url": "https://questionsmedicales.fr/article/36270994", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41467-022-33933-2" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Lipides", "item": "https://questionsmedicales.fr/mesh/D008055" }, { "@type": "ListItem", "position": 3, "name": "Lipides membranaires", "item": "https://questionsmedicales.fr/mesh/D008563" }, { "@type": "ListItem", "position": 4, "name": "Sphingolipides", "item": "https://questionsmedicales.fr/mesh/D013107" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Sphingolipides - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Sphingolipides", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-04-29", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Sphingolipides", "description": "Comment diagnostiquer une maladie liée aux sphingolipides ?\nQuels tests sont utilisés pour évaluer les sphingolipides ?\nLes symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?\nQuelle imagerie est utile pour les maladies des sphingolipides ?\nLes antécédents familiaux sont-ils importants pour le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Protein+Transport#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Sphingolipides", "description": "Quels sont les symptômes des troubles liés aux sphingolipides ?\nLes troubles digestifs sont-ils associés aux sphingolipides ?\nComment les sphingolipides affectent-ils le système nerveux ?\nLes troubles de la peau sont-ils fréquents avec les sphingolipides ?\nLes symptômes varient-ils selon le type de sphingolipide ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Protein+Transport#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Sphingolipides", "description": "Peut-on prévenir les maladies liées aux sphingolipides ?\nLes tests génétiques aident-ils à la prévention ?\nL'éducation sur les sphingolipides est-elle importante ?\nLes habitudes alimentaires influencent-elles la santé des sphingolipides ?\nLes vaccinations peuvent-elles aider à prévenir des complications ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Protein+Transport#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Sphingolipides", "description": "Quels traitements existent pour les maladies des sphingolipides ?\nLa diète peut-elle influencer les niveaux de sphingolipides ?\nLes médicaments peuvent-ils réduire les symptômes ?\nY a-t-il des traitements expérimentaux pour ces maladies ?\nLa thérapie génique est-elle une option pour ces maladies ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Protein+Transport#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Sphingolipides", "description": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?\nLes troubles respiratoires sont-ils une complication possible ?\nComment les sphingolipides affectent-ils le cœur ?\nLes complications neurologiques sont-elles fréquentes ?\nLes complications peuvent-elles être réversibles ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Protein+Transport#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Sphingolipides", "description": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?\nL'âge influence-t-il le risque de troubles des sphingolipides ?\nLes maladies auto-immunes sont-elles un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes infections peuvent-elles aggraver les troubles des sphingolipides ?", "url": "https://questionsmedicales.fr/mesh/D013107?mesh_terms=Protein+Transport#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une maladie liée aux sphingolipides ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests génétiques, des analyses biochimiques et des biopsies." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer les sphingolipides ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests sanguins et des analyses d'urine mesurent les niveaux de sphingolipides." } }, { "@type": "Question", "name": "Les symptômes peuvent-ils indiquer un déséquilibre des sphingolipides ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes neurologiques ou cutanés peuvent signaler un déséquilibre." } }, { "@type": "Question", "name": "Quelle imagerie est utile pour les maladies des sphingolipides ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'IRM et la TDM peuvent aider à visualiser les effets des maladies sur les organes." } }, { "@type": "Question", "name": "Les antécédents familiaux sont-ils importants pour le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents familiaux peuvent indiquer une prédisposition génétique aux maladies." } }, { "@type": "Question", "name": "Quels sont les symptômes des troubles liés aux sphingolipides ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des problèmes cutanés et des douleurs." } }, { "@type": "Question", "name": "Les troubles digestifs sont-ils associés aux sphingolipides ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles digestifs peuvent être liés à des anomalies des sphingolipides." } }, { "@type": "Question", "name": "Comment les sphingolipides affectent-ils le système nerveux ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Ils jouent un rôle dans la myélinisation et la signalisation neuronale, affectant la fonction nerveuse." } }, { "@type": "Question", "name": "Les troubles de la peau sont-ils fréquents avec les sphingolipides ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des affections cutanées comme l'eczéma peuvent être liées à des déséquilibres." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type de sphingolipide ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes dépendent du type de sphingolipide impliqué et de l'organe affecté." } }, { "@type": "Question", "name": "Peut-on prévenir les maladies liées aux sphingolipides ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les tests génétiques aident-ils à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque et guider la prévention." } }, { "@type": "Question", "name": "L'éducation sur les sphingolipides est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, comprendre les sphingolipides aide à reconnaître les symptômes et à agir rapidement." } }, { "@type": "Question", "name": "Les habitudes alimentaires influencent-elles la santé des sphingolipides ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation équilibrée peut soutenir la santé des sphingolipides et prévenir des troubles." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles aider à prévenir des complications ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les troubles liés aux sphingolipides." } }, { "@type": "Question", "name": "Quels traitements existent pour les maladies des sphingolipides ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des thérapies enzymatiques, des médicaments et des soins symptomatiques." } }, { "@type": "Question", "name": "La diète peut-elle influencer les niveaux de sphingolipides ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation riche en acides gras essentiels peut aider à réguler les sphingolipides." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils réduire les symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains médicaments peuvent atténuer les symptômes et améliorer la qualité de vie." } }, { "@type": "Question", "name": "Y a-t-il des traitements expérimentaux pour ces maladies ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des essais cliniques explorent de nouvelles thérapies pour les troubles des sphingolipides." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces maladies ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche pour traiter certaines maladies liées aux sphingolipides." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec les troubles des sphingolipides ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des troubles neurologiques graves, des infections et des défaillances organiques." } }, { "@type": "Question", "name": "Les troubles respiratoires sont-ils une complication possible ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles des sphingolipides peuvent entraîner des complications respiratoires." } }, { "@type": "Question", "name": "Comment les sphingolipides affectent-ils le cœur ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des déséquilibres peuvent contribuer à des maladies cardiovasculaires et à des arythmies." } }, { "@type": "Question", "name": "Les complications neurologiques sont-elles fréquentes ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des complications comme la démence ou des troubles moteurs peuvent survenir." } }, { "@type": "Question", "name": "Les complications peuvent-elles être réversibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les maladies des sphingolipides ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des déséquilibres nutritionnels." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de troubles des sphingolipides ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles apparaissent plus fréquemment chez les enfants ou les personnes âgées." } }, { "@type": "Question", "name": "Les maladies auto-immunes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de troubles liés aux sphingolipides." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "Les infections peuvent-elles aggraver les troubles des sphingolipides ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines infections peuvent exacerber les symptômes et les complications." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 10/03/2025

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

17 au total
└─

Glycosphingolipides

Glycosphingolipids D006028 - D10.570.877.360
└─└─

Glycosphingolipides acides

Acidic Glycosphingolipids D020384 - D10.570.877.360.025
└─└─

Glycosphingolipides neutres

Neutral Glycosphingolipids D020383 - D10.570.877.360.612
└─└─

Psychosine

Psychosine D011609 - D10.570.877.360.806
└─└─└─

Gangliosides

Gangliosides D005732 - D10.570.877.360.025.475
└─└─└─

Sulfoglycosphingolipides

Sulfoglycosphingolipids D013433 - D10.570.877.360.025.837
└─└─└─

Céramides

Ceramides D002518 - D10.570.877.360.612.200
└─└─└─

Sphingomyéline

Sphingomyelins D013109 - D10.570.877.360.612.870
└─└─└─└─

Ganglioside GM1

G(M1) Ganglioside D005677 - D10.570.877.360.025.475.390
└─└─└─└─

Ganglioside GM2

G(M2) Ganglioside D005678 - D10.570.877.360.025.475.400
└─└─└─└─

Ganglioside GM3

G(M3) Ganglioside D005679 - D10.570.877.360.025.475.510
└─└─└─└─

Cérébrosides

Cerebrosides D002554 - D10.570.877.360.612.200.250
└─└─└─└─

Globosides

Globosides D005915 - D10.570.877.360.612.200.425
└─└─└─└─

Lactosylcéramides

Lactosylceramides D007790 - D10.570.877.360.612.200.612
└─└─└─└─

Trihexosylcéramide

Trihexosylceramides D014281 - D10.570.877.360.612.200.906
└─└─└─└─└─

Galactosylcéramides

Galactosylceramides D005699 - D10.570.877.360.612.200.250.450
└─└─└─└─└─

Glucosylcéramides

Glucosylceramides D005963 - D10.570.877.360.612.200.250.490

Auteurs principaux

Erich Gulbins

3 publications dans cette catégorie

Affiliations :
  • Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
  • Department of Surgery, University of Cincinnati, Cincinnati, OH, United States.
Publications dans "Sphingolipides" :

Giovanni D'Angelo

3 publications dans cette catégorie

Affiliations :
  • Interfaculty Institute of Bioengineering, Ecole polytechnique fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland giovanni.dangelo@epfl.ch Christopher.Clarke@stonybrookmedicine.edu lianacsilva@ff.ulisboa.pt.
Publications dans "Sphingolipides" :

Anna Kovilakath

3 publications dans cette catégorie

Affiliations :
  • Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States.
Publications dans "Sphingolipides" :

L Ashley Cowart

3 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry and Molecular Biology and the Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
  • Richmond Veteran's Affairs Medical Center, Richmond, VA, United States.
Publications dans "Sphingolipides" :

Tyrone Dowdy

3 publications dans cette catégorie

Affiliations :
  • Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Publications dans "Sphingolipides" :

Mioara Larion

3 publications dans cette catégorie

Affiliations :
  • Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Publications dans "Sphingolipides" :

Anthony H Futerman

2 publications dans cette catégorie

Affiliations :
  • Department of Biomolecular Sciences, Weizmann Institute of Science, Rehovot, Israel.
Publications dans "Sphingolipides" :

Burkhard Kleuser

2 publications dans cette catégorie

Affiliations :
  • Department of Toxicology, University of Potsdam, Nuthetal, Germany.
Publications dans "Sphingolipides" :

Fabian Schumacher

2 publications dans cette catégorie

Affiliations :
  • Department of Toxicology, University of Potsdam, Nuthetal, Germany.
  • Department of Molecular Biology, University of Duisburg-Essen, Essen, Germany.
Publications dans "Sphingolipides" :

Hugo J Bellen

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX, United States.
  • Jan and Dan Duncan Neurological Research Institute, Texas Children's Hospital, Houston, TX, United States.
  • Department of Neuroscience, Baylor College of Medicine, Houston, TX, United States.
Publications dans "Sphingolipides" :

Stuart M Pitson

2 publications dans cette catégorie

Affiliations :
  • Centre for Cancer Biology, University of South Australia and SA Pathology, UniSA CRI Building, North Tce, Adelaide, SA 5001, Australia; Adelaide Medical School, University of Adelaide, Adelaide, SA 5001, Australia; School of Biological Sciences, University of Adelaide, Adelaide, SA 5000, Australia. Electronic address: stuart.pitson@unisa.edu.au.
Publications dans "Sphingolipides" :

Melissa Vos

2 publications dans cette catégorie

Affiliations :
  • Institute of Neurogenetics, University of Luebeck, Ratzeburger Allee 160, 23562 Lübeck, Germany.
Publications dans "Sphingolipides" :

Adrian Lita

2 publications dans cette catégorie

Publications dans "Sphingolipides" :

Lumin Zhang

2 publications dans cette catégorie

Publications dans "Sphingolipides" :

Mark R Gilbert

2 publications dans cette catégorie

Publications dans "Sphingolipides" :

Nawajes Mandal

2 publications dans cette catégorie

Affiliations :
  • Department of Ophthalmology, University of Tennessee Health Science Center, UTHSC, Memphis, TN, USA. nmandal@uthsc.edu.
  • Department of Anatomy and Neurobiology, University of Tennessee Health Science Center, UTHSC, Memphis, TN, USA. nmandal@uthsc.edu.

Maryam Jamil

2 publications dans cette catégorie

Affiliations :
  • Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, United States.
  • Department of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
Publications dans "Sphingolipides" :

Lauren Ashley Cowart

2 publications dans cette catégorie

Affiliations :
  • Department of Biochemistry and Molecular Biology, Massey Cancer Center, Virginia Commonwealth University, Richmond, VA, United States.
  • Richmond Veteran's Affairs Medical Center, Richmond, VA, United States.
Publications dans "Sphingolipides" :

Miroslav Machala

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.

Jiřina Procházková

2 publications dans cette catégorie

Affiliations :
  • Department of Chemistry and Toxicology, Veterinary Research Institute, Hudcova 296/70, 62100 Brno, Czech Republic.

Sources (10000 au total)